PMPRB
Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its virtual Western Day Conference on February 9th, 2021. Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion. This conference was dedicated to Steve Long, who passed away of cancer in 2019. He was a friend, mentor, and…
Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its first virtual Market Access 201 conference on November 24, 2020. Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion. Session 1. Keynote: Evolution of HTA in United States and the Impact on International Markets …
Consultations on Enhanced and Aligned Review Processes and Program Updates. CADTH released its Pharmaceutical Reviews Update — Issue 16 on June 25, 2020. It includes two consultations with respect to enhanced and aligned review processes, in addition to program update announcements. Highlights of the consultations and program updates are described below. Topic MORSE Note Consultations – Feedback due to CADTH by August 10, 2020 Consultation on Alignment of…
CADTH recently released their annual business plan for 2020-2021. In this, the last year of their three-year strategic plan, CADTH aims to deliver on a number of priority initiatives, several of which may have implications for industry, as described below. 1) Operationalize the Life Cycle Approach to Health Technology Assessment (HTA) Under this priority initiative, CADTH signals their continued commitment to the life cycle approach to HTA via: enhancement…
Toronto, February 18, 2020 – MORSE Consulting is pleased to expand and strengthen our service offering with the addition of Anita Carrie and Roy Cairns. Affordability of effective and innovative medications within the current Canadian public funding model is becoming very challenging for the healthcare system. Increasing budgetary constraints coupled with complex treatments requiring consideration of different sources and levels of evidence are an issue for all stakeholders. To help…
Development of a framework for the generation and use of Real-World Evidence for cancer drug funding. The CanREValue Collaboration hosted a webinar on November 6, 2019 to introduce their preliminary framework and to outline the Stakeholder Feedback process. The slide deck that was presented, along with a recording can be accessed from the CanREValue website. The purpose of the CanReValue Collaboration is to develop a framework for Canadian provinces…
Introduction MORSE Consulting is pleased to contribute its pCPA/public payer expertise with leading pricing and reimbursement experts and provide our respective views on how the new PMPRB regulations may impact the Canadian environment. These experts include: PMPRB: Joan McCormick, Principal Consultant - IQVIA HTA/Health Economics (HE): Sumeet Singh & Heather Cameron – Cornerstone Research Group Inc. Private Payers: Suzanne Lepage, Suzanne Lepage Consulting The purpose of this summary is two-fold:…
MORSE Consulting has prepared a summary of the key highlights from the Patented Medicines Prices Review Board’s (PMPRB) recent webinar on the release of their Meds Entry Watch 2017 report (third edition). Date: February 20th 2019 Time: 1pm-2pm Presented by: Elena Lungu (Manager NPDUIS, PMPRB), Jared Berger (Policy Analyst, Policy and Economic Analysis Branch, PMPRB) Objective: To present the Meds Entry Watch, 2017 report to interested stakeholders and allow an…
Summary of Expensive Drugs for Rare Diseases (EDRD) Working Group Webinar Signals Decoded: Stakeholder consultation is underway on a supplemental process for complex/specialized drugs that builds upon the existing national HTA and reimbursement process to make responsive funding decisions with a focus on non-oncology therapies. The supplemental process is a significant development in EDRD policy and it looks to streamline the evaluation and reimbursement process of eligible drugs…
Panel 6: Presidents’ Roundtable Panel Description: This session brought together general managers from three innovative pharmaceutical companies operating in Canada to explore their insights on how the current reimbursement environment is impacting their company, its decision-making and patient access. Moderator: Barbara Jaszewski Panelists: Peter Brenders, Brian Canestraro and Ben Faienza Barbara Jaszewski: CAHR 201 has been a great way to get a fast introduction to all the changes that…
Panel 4: Pan-Canadian Pharmaceutical Alliance Panel Description: This panel will focus on recent events surrounding the pCPA and how public payers believe that PMPRB reform may impact upcoming pCPA negotiations. Moderator: Sherry O’Quinn Panelists: Imran Ali, Jessica Arias and Heather McDonald Sherry O’Quinn: Our focus is on recent events around the pCPA and the pharmaceutical landscape. A lot of this discussion is framed around healthcare sustainability. Here to take…
PMPRB Panel On Tuesday, June 19, 2018, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was “Flying Blind – Navigating Patient Access through Uncertainty” which consisted of five fascinating panels focusing on important topics of interest for pharmaceutical stakeholders in Canada. Over the coming weeks, MORSE will be releasing summaries for each panel to share key insights from…
MORSE Consulting has prepared a brief summary of the key highlights from the Patented Medicine Prices Review Board's (PMPRB) recent webinar on the launch of the annual Compass Rx public drug plan expenditure report, 2016/17. Date: September 12th 2018, 1pm-2pm Presented by: Elena Lungu, Manager, NPDUIS, Policy and Economic Analysis Branch, PMPRB Objective: To provide the results of the most recent edition of Compass Rx, an initiative through the National…
MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place from April 15-17, 2018 in Halifax, Nova Scotia. Further details on MORSE, and its strategic partner’s (Cornerstone Research Group) participation can be found below. April 16, 2018 15:15-16:30 ADT Sherry O’Quinn moderates a panel on oncology drugs with Alex Chambers (CADTH), Scott Gavura (CCO), Elena Lungu…
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE LINKS provides a comprehensive list of useful web links which can allow market access professionals to easily access frequently referenced web sites. Similar to other services offered by MORSE, LINKS has a user-friendly interface with information separated into broad categories to allow users to sort and search based…
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
PMPRB - Info and details on - MORSE Consulting Inc.